Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

BACKGROUND: Low-dose aspirin is of definite and substantial net benefit for many people who already have occlusive vascular disease. We have assessed the benefits and risks in primary prevention. METHODS: We undertook meta-analyses of serious vascular events (myocardial infarction, stroke, or vascul...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Baigent, C, Blackwell, L, Collins, R, Emberson, J, Godwin, J, Peto, R, Buring, J, Hennekens, C, Kearney, P, Meade, T, Patrono, C, Roncaglioni, M, Zanchetti, A
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Elsevier 2009

Míreanna comhchosúla

Efficacy of aspirin in people with diabetes: an individual participant data meta-analysis of 26 randomised trials
de réir: Wong, C, et al.
Foilsithe / Cruthaithe: (2014)

Aspirin in the primary prevention of vascular disease Reply
de réir: Baigent, C, et al.
Foilsithe / Cruthaithe: (2009)

Aspirin in the primary prevention of vascular disease Reply
de réir: Baigent, C, et al.
Foilsithe / Cruthaithe: (2009)

Aspirin and stroke.
de réir: Buring, J, et al.
Foilsithe / Cruthaithe: (1990)

Aspirin in ischemic heart disease.
de réir: Hennekens, C, et al.
Foilsithe / Cruthaithe: (1992)

Low-dose aspirin for migraine prophylaxis.
de réir: Buring, J, et al.
Foilsithe / Cruthaithe: (1990)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
de réir: Hennekens, C, et al.
Foilsithe / Cruthaithe: (1989)

ASPIRIN USE AND CHRONIC DISEASES
de réir: Hennekens, C, et al.
Foilsithe / Cruthaithe: (1990)

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.
de réir: Kearney, P, et al.
Foilsithe / Cruthaithe: (2006)

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.
de réir: Kearney, P, et al.
Foilsithe / Cruthaithe: (2006)

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
de réir: Collins, R, et al.
Foilsithe / Cruthaithe: (1996)

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.
de réir: Rothwell, P, et al.
Foilsithe / Cruthaithe: (2012)

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials
de réir: Rothwell, P, et al.
Foilsithe / Cruthaithe: (2012)

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials
de réir: Rothwell, P, et al.
Foilsithe / Cruthaithe: (2012)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
de réir: Patrono, C, et al.
Foilsithe / Cruthaithe: (2010)

Prevention. Aspirin in primary prevention--good news and bad news.
de réir: Hennekens, C, et al.
Foilsithe / Cruthaithe: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
de réir: Hennekens, C, et al.
Foilsithe / Cruthaithe: (2012)

Role of aspirin in primary prevention of cardiovascular disease
de réir: Patrono, C, et al.
Foilsithe / Cruthaithe: (2019)

Randomised trial of prophylactic daily aspirin in British male doctors.
de réir: Peto, R, et al.
Foilsithe / Cruthaithe: (1988)

Benefit of aspirin plus angiotensin-converting enzyme inhibitor.
de réir: Baigent, C, et al.
Foilsithe / Cruthaithe: (2001)

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
de réir: Baigent, C, et al.
Foilsithe / Cruthaithe: (2003)

Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.
de réir: Patrono, C, et al.
Foilsithe / Cruthaithe: (2009)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
de réir: Hennekens, C, et al.
Foilsithe / Cruthaithe: (2006)

Low-dose aspirin for the prevention of atherothrombosis.
de réir: Patrono, C, et al.
Foilsithe / Cruthaithe: (2005)

Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
de réir: Patrono, C, et al.
Foilsithe / Cruthaithe: (2005)

Immediate aspirin for suspected ischaemic stroke.
de réir: Baigent, C, et al.
Foilsithe / Cruthaithe: (1999)

An overview of the British and American aspirin studies.
de réir: Hennekens, C, et al.
Foilsithe / Cruthaithe: (1988)

Antioxidant vitamins--benefits not yet proved.
de réir: Hennekens, C, et al.
Foilsithe / Cruthaithe: (1994)

Antioxidant vitamins, cancer, and cardiovascular disease - Reply
de réir: Hennekens, C, et al.
Foilsithe / Cruthaithe: (1996)

BETA-CAROTENE, VITAMIN-E, AND LUNG-CANCER
de réir: Hennekens, C, et al.
Foilsithe / Cruthaithe: (1994)

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
de réir: Collins, R, et al.
Foilsithe / Cruthaithe: (1997)

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
de réir: Kearney, P, et al.
Foilsithe / Cruthaithe: (2008)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
de réir: Emberson, J, et al.
Foilsithe / Cruthaithe: (2012)

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
de réir: Collins, R, et al.
Foilsithe / Cruthaithe: (1994)

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
de réir: Baigent, C, et al.
Foilsithe / Cruthaithe: (1998)

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
de réir: Baigent, C, et al.
Foilsithe / Cruthaithe: (2010)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
de réir: Mihaylova, B, et al.
Foilsithe / Cruthaithe: (2012)

Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
de réir: Rothwell, P, et al.
Foilsithe / Cruthaithe: (2018)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
de réir: Baigent, C, et al.
Foilsithe / Cruthaithe: (2005)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised controlled trials of statins (vol 366, pg 1267, 2005)
de réir: Baigent, C, et al.
Foilsithe / Cruthaithe: (2008)